NASDAQ: PBMPsyence Biomedical Ltd Stock Ownership - Who owns Psyence Biomedical?
Insider buying vs selling
Have Psyence Biomedical Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when PBM insiders and whales buy or sell their stock.
PBM Shareholders
What type of owners hold Psyence Biomedical Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Marc Gregory Balkin | 1,312.45% | 7,455,000 | $24.23M | Insider |
| Newcourt Spac Sponsor LLC | 161.97% | 920,000 | $2.99M | Insider |
| Polar Asset Management Partners Inc | 93.31% | 530,000 | $1.72M | Insider |
| Parallel Advisors LLC | 48.41% | 275,000 | $893.75k | Institution |
| Sabby Management LLC | 3.58% | 20,328 | $66.07k | Institution |
| Advisorshares Investments LLC | 0.78% | 4,448 | $14.46k | Institution |
| Goldman Sachs Group Inc | 0.66% | 3,749 | $12.18k | Insider |
| Bank Of America Corp | 0.59% | 3,340 | $10.86k | Institution |
| Ubs Group Ag | 0.34% | 1,956 | $6.36k | Institution |
| Stonehage Fleming Financial Services Holdings Ltd | 0.10% | 561 | $1.82k | Institution |
PBM vs Biotech Stocks
Psyence Biomedical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.